Data Presented at the 2019 American Urological Association (AUA) Annual Meeting Showcases Potential for Progenics’ PyL Imaging Agent

NEXT STORY
Turning Point Therapeutics and Almac Diagnostic Services Announce Approval of an Investigational Device Exemption for the Companion Diagnostic Assay to the Registrational TRIDENT-1 Clinical Study
PREV STORY
CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EUROPESE COMMISSIE VERLEENT HANDELSVERGUNNING VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE REUMATOïDE ARTRITIS

author_avatar
NASDAQ Market News

Global Opioids Market to Reach $29.4 Billion by 2024 – Asia Pacific is Expected to Witness the Fastest Growth Over the Forecast Period

author_avatar
NASDAQ Market News

G1 Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Dec. 06, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

author_avatar
NASDAQ Market News